United States securities and exchange commission logo




                                                                                
                          April 3, 2024

       Kevin Danahy
       President and Chief Executive Officer
       Pulse Biosciences, Inc.
       3957 Point Eden Way
       Hayward, California 94545

                                                        Re: Pulse Biosciences, 
Inc.
                                                            Registration 
Statement on Form S-3
                                                            Filed March 28, 
2024
                                                            File No. 333-278322

       Dear Kevin Danahy:

              This is to advise you that we have not reviewed and will not 
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for 
acceleration. We remind you
       that the company and its management are responsible for the accuracy and 
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of 
action by the staff.

                                                        Please contact Robert 
Augustin at 202-551-8483 with any questions.



                                                                                
                          Sincerely,

                                                                                
                          Division of Corporation Finance
                                                                                
                          Office of Industrial Applications and
                                                                                
                          Services
       cc:                                              Adam Finerman